Details

Last Funding Type

Series B

Last Funding Money Raised

$20M

Industries

Biotechnology,Genetics,Medical Device,Therapeutics

Founded date

Jan 1, 2009

Number Of Employee

11 - 50

Operating Status

Active

LoneStar Heart is a biomedical company developing new therapies to preserve and restore adequate heart function in patients with Advanced Heart Failure (HF). Based on its integrated card mechanical and biomolecular technologies, the privately-held company is developing a broad portfolio of products to restore the failing heart’s structure and function in collaboration with the University of Texas Southwestern Medical Center, Texas Heart Institute, and a global network of leading clinicians. These products include Algisyl-LVR, small molecule cardiac stem-cell modulators, and cellular and genetic therapies delivered as stand-alone treatments, or in combination with the company’s proprietary biopolymer hydrogel matrix system.